These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9157781)

  • 1. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development.
    Bellahcene A; Kroll M; Liebens F; Castronovo V
    J Bone Miner Res; 1996 May; 11(5):665-70. PubMed ID: 9157781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers.
    Waltregny D; Bellahcène A; de Leval X; Florkin B; Weidle U; Castronovo V
    J Bone Miner Res; 2000 May; 15(5):834-43. PubMed ID: 10804012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
    Diel IJ; Solomayer EF; Seibel MJ; Pfeilschifter J; Maisenbacher H; Gollan C; Pecherstorfer M; Conradi R; Kehr G; Boehm E; Armbruster FP; Bastert G
    Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases.
    Bellahcène A; Castronovo V
    Bull Cancer; 1997 Jan; 84(1):17-24. PubMed ID: 9180854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.
    Zhang JH; Tang J; Wang J; Ma W; Zheng W; Yoneda T; Chen J
    Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer.
    Bellahcène A; Merville MP; Castronovo V
    Cancer Res; 1994 Jun; 54(11):2823-6. PubMed ID: 8187059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
    Mihai R; Stevens J; McKinney C; Ibrahim NB
    Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels.
    Bellahcène A; Antoine N; Clausse N; Tagliabue E; Fisher LW; Kerr JM; Jarès P; Castronovo V
    Lab Invest; 1996 Aug; 75(2):203-10. PubMed ID: 8765320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.
    Detry C; Lamour V; Castronovo V; Bellahcène A
    Bone; 2008 Feb; 42(2):422-31. PubMed ID: 18088579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of human bone sialoprotein in normal and pathological tissues using a monoclonal antibody (BSP 1.2 mab).
    Cogan G; Bansal AK; Ibrahim S; Zhu B; Goldberg HA; Ganss B; Cheifetz S; Armbruster FP; Sodek J
    Connect Tissue Res; 2004; 45(1):60-71. PubMed ID: 15203941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
    Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
    Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells.
    Gordon JA; Sodek J; Hunter GK; Goldberg HA
    J Cell Biochem; 2009 Aug; 107(6):1118-28. PubMed ID: 19492334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA; Mamoon N; Mushtaq S; Khadim MT
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PTHrP and bone sialoprotein as prognostic markers for developing bone metastases in breast cancer patients].
    Loibl S; Königs A; Kaufmann M; Costa SD; Bischoff J
    Zentralbl Gynakol; 2006 Dec; 128(6):330-5. PubMed ID: 17213971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells.
    Zhang JH; Wang J; Tang J; Barnett B; Dickson J; Hahsimoto N; Williams P; Ma W; Zheng W; Yoneda T; Pageau S; Chen J
    Anticancer Res; 2004; 24(3a):1361-8. PubMed ID: 15274296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
    Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
    Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.